Thermo Fisher Scientific / Olink merger inquiry
The CMA is investigating the anticipated acquisition by Thermo Fisher Scientific Inc. of Olink Holding AB.
Statutory timetable
| Phase 1 | Action |
| 8 July 2024 | Deadline for phase 1 decision (*) |
| 10 May 2024 | Launch of merger inquiry |
| 2 February 2024 to 23 February 2024 | Invitation to comment |
(*) This date is the current statutory deadline by when the decision will be announced. If any change occurs, the information is refreshed as soon as practicable. However, the CMA cannot guarantee that the decision will be announced on or before this current deadline, as the deadline of a given case may change during the merger assessment process due to different reasons.
Phase 1
Launch of merger inquiry
10 May 2024: The CMA announced the launch of its merger inquiry by notice to the parties.
- (10.5.24)
Invitation to comment: closed
2 February 2024: The Competition and Markets Authority (CMA) is considering whether it is or may be the case that this transaction, if carried into effect, will result in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation may be expected to result in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.
To assist it with this assessment, the CMA invites comments on the merger from any interested party.
These comments should be provided by the deadline set out above.
Contact
Please send written representations about any competition or public interest to Carmelo.Franceschino@cma.gov.uk.
Last updated 10 May 2024 + show all updates
-
Commencement notice published.
-
First published.